Key Takeaways
- Verdesian Life Sciences has completed a strategic buildout of its commercial leadership team spanning sales, business development, marketing and customer engagement.
- Recent hires include John Dombrosky as Vice President of Business Development, Chris Wiley as Vice President of Sales for the East Region, and Tyler Brown as Vice President of Sales for the Central Region.
- The new leaders bring experience from companies including FMC Corporation, Syngenta, Corteva Agriscience, Ohalo Genetics, Oerth Bio, Timac Agro and Thomson Reuters.
- The effort builds on earlier additions of Chief Revenue Officer Nick Ebert and Vice President of Global Marketing John Price, who joined the company in 2025.
- CEO Clare Doyle said the expanded team supports the company's ability to serve customers as it scales its product portfolio.
Verdesian Life Sciences Adds Sales and Business Development Leaders
Verdesian Life Sciences has completed an 18-month buildout of its commercial leadership team, adding leaders across sales, business development, marketing and customer engagement to support its long-term growth strategy across North America. The most recent additions include John Dombrosky as Vice President of Business Development, Chris Wiley as Vice President of Sales for the East Region, and Tyler Brown as Vice President of Sales for the Central Region. The new hires bring experience from companies including FMC Corporation, Syngenta, Corteva Agriscience, Ohalo Genetics, Oerth Bio, Timac Agro and Thomson Reuters.
CEO Cites Growing Customer Demands
Clare Doyle, Chief Executive Officer of Verdesian Life Sciences, said the expanded team supports the company's ability to serve a growing customer base. “Over the past several years, Verdesian has continued to evolve, expanding both our product portfolio and our ability to serve customers across the agricultural value chain. Building a world-class commercial organization to match our industry-leading R&D capabilities has been a key strategic priority. As growers increasingly focus on maximizing the return on every input dollar and prioritize technologies that deliver measurable agronomic and economic value, these additions strengthen our ability to support customers, deepen partnerships, and accelerate execution as we continue to scale,” said Clare Doyle, Chief Executive Officer of Verdesian Life Sciences.
Verdesian Life Sciences Builds on 2025 Leadership Additions
The recent hires build on a broader commercial transformation led by Chief Revenue Officer Nick Ebert and Vice President of Global Marketing John Price, who both joined the company in 2025. Working with Doyle, the two have led efforts to strengthen go-to-market capabilities and deepen customer and distribution partner relationships across key crop segments and geographies. “We've been intentional about building a team that combines deep agronomic expertise, commercial discipline, and strong customer relationships. With these additions, we have assembled a core leadership group capable of supporting customers at a higher level while helping drive Verdesian's next phase of growth,” said Nick Ebert, Chief Revenue Officer of Verdesian Life Sciences.
John Price, Vice President of Global Marketing, said the marketing organization has also been restructured over the same period. “We've transformed our marketing efforts into a strategic growth engine for Verdesian. Working hand-in-hand with our talented team, we've succeeded in sharpening our portfolio, amplifying our brand, and strengthening engagement across our partners and audience streams. Together with the expanded commercial team, we will continue delivering exceptional value to our customers while positioning the company for its next phase of growth,” said John Price, Vice President, Global Marketing at Verdesian Life Sciences.
